Stay updated on T-VEC + Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T05:15:17.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:52:14.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest version as v2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    1.0%
    Check dated 2025-08-02T19:41:29.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new revision (v2.16.8) and a new last update date of July 25, 2025, while previous dates and an older revision (v2.16.6) have been removed.
    Difference
    0.9%
    Check dated 2025-07-26T15:39:13.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.1%
    Check dated 2025-07-19T11:53:35.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    A service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    0.9%
    Check dated 2025-07-12T08:04:41.000Z thumbnail image

Stay in the know with updates to T-VEC + Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.